CoSara Diagnostics gets permission from CDSCO for SARAQ™ Hepatitis C Viral Load Kit as an IVD

CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc, Salt Lake City, Utah, USA recently got permission to manufacture and sell its SARAQ™ Hepatitis C ("HCV") Viral Load Kit as an in vitro diagnostic ("IVD") from CDSCO.

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens our foundation for future growth. Effective HCV treatments are especially useful when used in tandem with tests for diagnosing and monitoring those therapies. This HCV Viral Load kit test adds to our expanding menu of valuable diagnostic tools available to our growing distributor and laboratory customer base.

Shares of AMBALAL SARABHAI ENTERPRISES LTD. was last trading in BSE at Rs. 35.15 as compared to the previous close of Rs. 35.45. The total number of shares traded during the day was 125049 in over 447 trades.

The stock hit an intraday high of Rs. 36.00 and intraday low of 35.00. The net turnover during the day was Rs. 4430755.00.

Source : Equity Bulls

Keywords

AMBALALSARABHAIENTERPRISES INE432A01017 CoSaraDiagnostics CDSCO Permission HepatitisC ViralLoadKit